Enanta Pharmaceuticals Company

Enanta’s chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus (RSV), hepatitis B virus (HBV), non-alcoholic steatohepatitis (NASH), human metapneumovirus (hMPV) and SARS-CoV-2. Learn more about our research.
Technology: COVID
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership